CoChat

Fulminant Hepatic Failure Associated with 2′,3′-Dideoxyinosine (ddI)

Lai, Kwan Kew, Gang, David L., Zawacki, John K., Cooley, Timothy P. · 1991 · Annals of Internal Medicine
Cited by 157

The DOI matches its Crossref record.

Abstract

Brief Reports15 August 1991Fulminant Hepatic Failure Associated with 2′,3′-Dideoxyinosine (ddI)Kwan Kew Lai, DMD, MD, David L. Gang, MD, John K. Zawacki, MD, Timothy P. Cooley, MDKwan Kew Lai, DMD, MD, David L. Gang, MD, John K. Zawacki, MD, Timothy P. Cooley, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-115-4-283 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptResults from recently published phase I trials (1-3) of 2′,3′-dideoxyinosine (didanosine, ddI) show promise in the treatment of patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex; ddI is currently being evaluated in phase II-III clinical trials and is widely available in an expanded access program. The major clinical toxicities associated with ddI include peripheral neuropathy and pancreatitis. Deaths have been associated with severe cases of pancreatitis. Laboratory abnormalities include hyperuricemia and elevated levels of hepatic aminotransferases. We report a patient with fulminant hepatic failure associated with the use of ddI.A 36-year-old homosexual man with the Gilbert syndrome,...References1. Yarchoan R, Mitsuya H, Thomas R, Pluda J, Hartman N, and Perno C. In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxyinosine. Science. 1989;245:412-5. CrossrefMedlineGoogle Scholar2. Lambert J, Seidlin M, Reichman R, Plank C, Laverty M, and Morse G. 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial. N Engl J Med. 1990;322:1330-40. CrossrefGoogle Scholar3. Cooley T, Kunches L, Saunders C, Perkins C, Kelley S, and McLaren C. Treatment of AIDS and AIDS-related complex with 2′,3′-dideoxyinosine given once daily. Rev Infect Dis. 1990;12:S552-60. CrossrefMedlineGoogle Scholar4. Chaves-Carballo E, Gomez M, and Sharbrough F. Encephalopathy and fatty infiltration of the viscera (Reye-Johnson syndrome): a 17-year experience. Mayo Clin Proc. 1975;50:209-15. MedlineGoogle Scholar5. Peters R, Edmondson H, Mikkelsen W, and Tatter D. Tetracyclineinduced fatty liver in nonpregnant patients. A report of six cases. Am J Surg. 1967;113:622-32. CrossrefMedlineGoogle Scholar6. Powell-Jackson P, Tredger J, and Williams R. Hepatotoxicity to sodium valproate: a review. Gut. 1984;25:673-81. CrossrefMedlineGoogle Scholar7. Sheratt J. Hypoglycin, the famous toxin of the unripe Jamaican ackee fruit. Trends in Pharmacological Sciences. 1986;7:186-91. CrossrefGoogle Scholar8. Geneve J, Hayat-Bonan B, Labbe G, DeGott C, Letteron P, and Freneaux E. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug. J Pharmacol Exp Ther. 1987;242:1133-7. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: Kwan Kew Lai, DMD, MD; David L. Gang, MD; John K. Zawacki, MD; Timothy P. Cooley, MDFrom the University of Massachusetts Medical Center and the University of Massachusetts Medical School, Worcester, Massachusetts; and Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts. For current author addresses, see end of text. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byHepatic Injury due to Drugs, Dietary and Herbal Supplements, Chemicals and ToxinsTrimetazidine enhances myocardial angiogenesis in pressure overload-induced cardiac hypertrophy mice through directly activating Akt and promoting the binding of HSF1 to VEGF-A promoterSuccessful Treatment of Tenofovir Alafenamide-Induced Lactic Acidosis: A Case ReportA 3D cell printing-fabricated HepG2 liver spheroid model for high-content in situ quantification of drug-induced liver toxicityLiver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?Insights into the antiviral activity of phospholipases A2 (PLA2s) from snake venomsDecreased All-Cause and Liver-Related Mortality Risk in HIV/Hepatitis B Virus Coinfection Coinciding With the Introduction of Tenofovir-Containing Combination Antiretroviral TherapyMedikamentös-toxischer Leberschaden (DILI)The Role of Liver Biopsy in Drug-Induced Liver InjuryUnanticipated Risk in Clinical Research ∗ ∗The editors have included Dr. Stephen Straus'original unedited contribution, penned for the book's 2002 edition and published with minor modification in the second edition in 2007, to honor his memory. This is a classic and compelling chapter with a story that remains relevant today. References to regulation and guidelines may not be current. The editors have added current references as of the time of publication to the end of the chapter.Drugs and ToxinsThe histopathological evaluation of drug-induced liver injuryHAART toxicity masquerading as a surgical abdomenDrug-Induced Liv

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-115-4-283

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 157

Metadata

Authors
Lai, K. K., Gang, D. L., Zawacki, J. K., & Cooley, T. P.
Venue
Annals of Internal Medicine
Published
1991-08-15
Volume
115
Issue
4
Pages
283-284
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2031577449
Cited by
157
References
0
FWCI
6.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fulminant Hepatic Failure Associated with 2′,3′-Dideoxyinosine (ddI). https://app.cochat.ai/papers/10.7326/0003-4819-115-4-283
The paper
Lai, K. K., Gang, D. L., Zawacki, J. K., & Cooley, T. P. (1991). Fulminant Hepatic Failure Associated with 2′,3′-Dideoxyinosine (ddI). Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-115-4-283

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.